Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators. [electronic resource]
Producer: 19970623Description: 1015-21 p. digitalISSN:- 0039-2499
- Adult
- Aged
- Anticoagulants -- adverse effects
- Atrial Fibrillation -- drug therapy
- Cyclooxygenase Inhibitors -- adverse effects
- Female
- Follow-Up Studies
- Humans
- Isoindoles
- Male
- Middle Aged
- Phenylbutyrates -- adverse effects
- Prospective Studies
- Treatment Outcome
- Vascular Diseases -- prevention & control
- Warfarin -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.